EUCTR2006-006706-29-NL进行中（未招募）1 期
Does atorvastatin reduce ischemia-reperfusion injury in humans in-vivo? - ator
MCN department Pharm-Tox0 个研究点目标入组 20 人开始时间: 2006年12月22日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-Age 18-50 years
- •-Informed consent
- •-Physical able to perform ischemic exercise
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- History of any cardiovascular disease
- •- Hypertension (in supine position: systole > 140 mmHg, diastole > 90 mmHg)
- •- Diabetes mellitus (fasting glucose > 7.0 mmol/L or random glucose > 11.0 mmol/L)
- •- Hyperlipidaemia (fasting total cholesterol > 5.5 mmol/l)
- •- Alanine-Amino-Transferase (ALAT) >90 U/L (more than twice the upper level of the normal range)
- •- Creatinine Kinase (CK) >340 U/L (more than twice the upper level of the normal range)
- •- Drug abuse
- •- Concomitant chronic use of medication
- •- Administration of radioactivity in research setting during the last 5 years
- •- Participation to any drug-investigation during the previous 60 days as checked with VIP check according to CRCN standard procedures
研究者
相似试验
尚未招募
不适用
Does atorvastatin reduce ischemia-reperfusion injury in humans in-vivo?myocardial infarctionischemia reperfusion injury10011082NL-OMON30203niversitair Medisch Centrum Sint Radboud12
已完成
2 期
Rosuvastatin and Ischemia ReperfusionIschemiaNCT00315510Radboud University Medical Center20
已完成
4 期
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?Ischemia Reperfusion InjuryCardiovascular DiseaseNCT00441597Radboud University Medical Center30
尚未招募
3 期
The effect of atorvastatin on Covid 19IRCT20210426051090N1Shahre-kord University of Medical Sciences80
已完成
3 期
Impact of ATOrvastatin REload on the Prevention of Contrast-INduced Nephropathy in patients on Chronic Statin Therapy: A prospective randomized trial (ATORE-CIN)renal diseasesPACTR202110707328144hedi chaker hospital102